Tag

Compounded Drugs

All articles tagged with #compounded drugs

health1 month ago•6 min saved

Telehealth GLP-1 Dose Errors Prompt Hospitalization

A NBC News and KFF Health News investigation finds safety gaps in telehealth prescribing of GLP-1 weight-loss drugs, highlighted by a North Carolina woman who was hospitalized after an overdose from dosing instructions she received online. With about 11% of U.S. adults using GLP-1s and a 1,500% increase in overdose/side-effect calls to poison centers from 2019–2025, experts warn that telehealth can lack critical oversight and proper dosing checks, particularly with compounded drugs not reviewed by the FDA. Advocates urge stronger provider access, clearer dosing protocols, and safer sourcing to protect patients.

via TODAY.com|

#compounded-drugs #glp-1-weight-loss #health

health5 months ago•14 min saved

Lilly warns of unknown safety risks in tirzepatide-B12 compounded drugs

Eli Lilly issued a public warning about potential patient safety risks from compounded tirzepatide mixed with vitamin B12, including a newly identified impurity with unknown short- and long-term effects. The company says these compounded tirzepatide-B12 products lack safety monitoring and adverse-event reporting, has alerted the FDA, and urges patients to discuss alternatives with their physicians. Lilly also cautions about broader safety issues and contaminants in other unregulated tirzepatide knockoffs and calls for regulator action to curb mass compounding in favor of FDA-approved therapies like Mounjaro and Zepbound.

via Eli Lilly|

#compounded-drugs #fda #health

health5 months ago•1 min saved

FDA Warns 30 Telehealth Firms Over Misleading GLP-1 Claims

The FDA issued 30 warning letters to telehealth companies for misleading marketing of compounded GLP-1 products, the second wave in a crackdown on direct-to-consumer pharmaceutical ads. The letters allege claims of sameness with FDA-approved products and branding that obscures sourcing. Compounded drugs are not FDA-approved and are not the same as generics, as the FDA does not review their safety or efficacy before marketing.

via fda.gov|

#compounded-drugs #fda #glp-1

health6 months ago•2 min saved

Hims & Hers halts compounded Wegovy copy amid federal probe

Hims & Hers will stop selling a cheaper, compounded version of Novo Nordisk’s obesity pill Wegovy after health officials called for an investigation into possible federal-law violations; the platform had offered a $49/month compounded version, while Novo Nordisk’s Wegovy costs $149–$299/month, as FDA and HHS/DOJ actions move to curb unapproved compounded GLP-1 drugs.

via statnews.com|

#compounded-drugs #glp-1 #health

health11 months ago•10 min saved

Emerging Trends in Weight Loss Medications and Market Dynamics

Despite FDA efforts to curb the sale of cheap, off-brand GLP-1 weight loss drugs like Ozempic, these medications are still widely available through pharmacies exploiting legal loopholes, driven by high demand and high prices of brand-name drugs, highlighting ongoing issues in drug accessibility and regulation in the US.

via Business Insider|

#compounded-drugs #fda-regulations #health

business1 year ago•0 min saved

Novo Nordisk intensifies legal efforts to combat illegal compounded Wegovy and protect US patients

Novo Nordisk has filed 14 lawsuits against vendors selling cheaper compounded versions of its obesity drug Wegovy (semaglutide), intensifying its legal efforts to protect its product.

via Seeking Alpha|

#business #compounded-drugs #legal-battle

health2 years ago•3 min saved

Exploring Alternatives to Ozempic for Weight Loss in the US

Many Americans seeking to lose weight are turning to alternatives to Ozempic, a new "wonder drug" for obesity. Compounded semaglutide, the active ingredient in Ozempic, is being sought out due to cost and supply issues with brand name drugs. However, experts and officials have raised concerns about the possible risks of compounded weight loss drugs. The soaring demand for these medications, fueled by their effectiveness and celebrity endorsements, has led to shortages and restrictions. The US FDA warns that compounded drugs pose a higher risk to patients and has received adverse event reports related to compounded semaglutide. Despite the uncertainties, individuals like Marissa Montanino are experiencing weight loss success and intend to continue using the drugs.

via Yahoo News|

#compounded-drugs #health #medication

health2 years ago•3 min saved

FDA Issues Warning on Compounded Ketamine

The FDA is warning people to avoid compounded ketamine, which is being sold as a treatment for depression and other mental health issues without being tested or authorized for such uses. The agency has received reports of people being harmed by these products, which are often marketed and sold through telemedicine companies. Compounded ketamine can be taken without supervision and the dosages can vary widely, posing potential risks to individuals. While ketamine-based therapies show promise for mental health conditions, the FDA emphasizes that there is no evidence to suggest that compounded ketamine is safer or more effective than FDA-approved medications.

via Gizmodo|

#compounded-drugs #depression #fda

health2 years ago•3 min saved

FDA Raises Concerns Over Misuse and Dangers of Ketamine Therapy

The FDA has issued a warning about the dangers of using compounded versions of ketamine for the treatment of psychiatric disorders. Compounded drugs are modified versions tailored to individual patients. The unsupervised use of compounded ketamine can lead to dangerous psychiatric reactions and health problems such as increased blood pressure, respiratory depression, and urinary tract issues. The FDA emphasized the importance of differentiating between supervised use of ketamine in clinics and wellness centers versus online marketers who prescribe the drug via telemedicine. The use of ketamine for psychiatric purposes, except for esketamine nasal spray, is unapproved and unregulated. The pandemic-related rise in telehealth has led to an increase in online prescribers dispensing ketamine, raising concerns about misuse and addiction. The FDA's alert did not include data on adverse reactions but cited a case of respiratory depression in a patient who took compounded oral ketamine outside of a healthcare setting.

via The New York Times|

#compounded-drugs #fda #health

health3 years ago•6 min saved

Exploring the Safety and Alternatives of Weight-Loss Drugs like Ozempic

The demand for weight loss drugs like Ozempic, Wegovy, and Mounjaro has surged, but many people face obstacles in accessing these medications due to prescription and insurance coverage issues. As a result, a niche industry of compounding pharmacies has emerged, offering knockoff versions of these drugs. However, the FDA has issued a warning about the potential dangers of compounded semaglutide, citing reports of unexpected health problems. Compounded drugs are not regulated by the FDA, raising concerns about their safety and efficacy. Experts caution against using these drugs due to the risks involved and the lack of nutritional counseling that typically accompanies legitimate weight loss medications.

via Everyday Health|

#compounded-drugs #fda-warning #health

health3 years ago•10 min saved

FDA's Ozempic Warning Ignored by Users.

The FDA has warned that compounded versions of semaglutide, a drug used for weight loss and diabetes treatment, could cause dangerous side effects. However, the high cost of name-brand options has led some patients to ignore the warning and turn to compounded versions. Compounding pharmacies are not regulated by the FDA, and the active ingredients in compounded semaglutide may not be FDA-approved. Despite the risks, many patients are turning to compounded versions due to the cost. Doctors warn that the potential harm of compounded semaglutide may not be worth the low cost.

via Rolling Stone|

#compounded-drugs #diabetes #fda-warning

health3 years ago•1 min saved

FDA warns against using generic weight loss drugs.

The FDA has warned consumers against using off-brand versions of popular weight-loss drugs Ozempic, Rybelsus, and Wegovy, as they may contain different ingredients from the brand-name drugs that are neither safe nor effective. Compounded versions of the drug's active ingredient, semaglutide, have been reported to cause problems. Compounded drugs are not FDA-approved, and the agency does not verify their safety or effectiveness. Some states have raised concerns about the safety of some of the compounded drugs, and states have tried to take action to curb their manufacturing.

via The Hill|

#compounded-drugs #fda #health